Sequence-based deep learning antibody design for in silico antibody affinity maturation
Antibody therapeutics has been extensively studied in drug discovery and development within the past decades. One increasingly popular focus in the antibody discovery pipeline is the optimization step for therapeutic leads. Both traditional methods and in silico approaches aim to generate candidates with high binding affinity against specific target antigens. Traditional in vitro approaches use hybridoma or phage display for candidate selection, and surface plasmon resonance (SPR) for evaluation, while in silico computational approaches aim to reduce the high cost and improve efficiency by incorporating mathematical algorithms and computational processing power in the design process. In the present study, we investigated different graph-based designs for depicting antibody-antigen interactions in terms of antibody affinity prediction using deep learning techniques. While other in silico computations require experimentally determined crystal structures, our study took interest in the capability of sequence-based models for in silico antibody maturation. Our preliminary studies achieved satisfying prediction accuracy on binding affinities comparing to conventional approaches and other deep learning approaches. To further study the antibody-antigen binding specificity, and to simulate the optimization process in real-world scenario, we introduced pairwise prediction strategy. We performed analysis based on both baseline and pairwise prediction results. The resulting prediction and efficiency prove the feasibility and computational efficiency of sequence-based method to be adapted as a scalable industry practice.
Code (0)
등록된 구현이 없습니다.
Tasks
Computational EfficiencyDrug DiscoveryPredictionSpecificitySimilar Papers 제목 키워드 기반
Llama-Affinity: A Predictive Antibody Antigen Binding Model Integrating Antibody Sequences with Llama3 Backbone Architecture
Antibody-facilitated immune responses are central to the body's defense against pathogens, viruses, and other foreign invaders. The ability of antibodies to specifically bind and neutralize antigens is vital for maintain…
Computational EfficiencyAntBO: Towards Real-World Automated Antibody Design with Combinatorial Bayesian Optimisation
Antibodies are canonically Y-shaped multimeric proteins capable of highly specific molecular recognition. The CDRH3 region located at the tip of variable chains of an antibody dominates antigen-binding specificity. There…
Bayesian OptimisationBenchmarkingSpecificityAntibodyFlow: Normalizing Flow Model for Designing Antibody Complementarity-Determining Regions
Therapeutic antibodies have been extensively studied in drug discovery and development in the past decades. Antibodies are specialized protective proteins that bind to antigens in a lock-to-key manner. The binding streng…
Drug DiscoveryvalidGuided Sequence-Structure Generative Modeling for Iterative Antibody Optimization
Therapeutic antibody candidates often require extensive engineering to improve key functional and developability properties before clinical development. This can be achieved through iterative design, where starting molec…
Stable Online and Offline Reinforcement Learning for Antibody CDRH3 Design
The field of antibody-based therapeutics has grown significantly in recent years, with targeted antibodies emerging as a potentially effective approach to personalized therapies. Such therapies could be particularly bene…
reinforcement-learningReinforcement Learning